Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLGW) Depreciation and Depletion (2016 - 2017)

Bone Biologics (BBLGW) has disclosed Depreciation and Depletion for 2 consecutive years, with $24.0 as the latest value for Q4 2017.

  • Quarterly Depreciation and Depletion fell 40.0% to $24.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $96.0 through Dec 2017, down 86.29% year-over-year, with the annual reading at $50.0 for FY2019, 47.92% down from the prior year.
  • Depreciation and Depletion for Q4 2017 was $24.0 at Bone Biologics, roughly flat from $24.0 in the prior quarter.
  • The five-year high for Depreciation and Depletion was $580.0 in Q1 2016, with the low at $24.0 in Q1 2017.